Angiologicka ambulance s.r.o.

Hlucin 5 trials 1 recruiting

5 Registered trials

1 Currently recruiting

Organisation

Angiologicka ambulance s.r.o.

Location

Hlucin, Czechia

Identifier

ORG-100046091

Address

Cs. Armady 12c/2052, 748 01, Czechia

Departments

#2104; Angiologicka ambulance
#3174:Angiologická ambulance
2307: Kardiologie
3174: Angiologicka ambulance

Clinical trials at this site (5)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08